Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP Pharma says AstraZeneca ends partnership on pediatric asthma drug unit dose budesonide
MAP Pharma says AstraZeneca ends partnership on pediatric asthma drug unit dose budesonide
MAP Pharma says AstraZeneca ends partnership on pediatric asthma drug unit dose budesonide
Submitted by
admin
on July 9, 2009 - 10:57pm
Source:
Yahoo/AP
News Tags:
MAP Pharmaceuticals
AstraZeneca
partnerships
asthma
Headline:
MAP Pharma says AstraZeneca ends partnership on pediatric asthma drug unit dose budesonide
Do Not Allow Advertisers to Use My Personal information
